- OPRX Platform
- Healthcare Partners
- News & Resources
- Investor Relations
- Press & Events
- Stock Information
- Investor Resources
- Schedule Demo
Genetic markers alone don’t typically drive patient disposition. They drive odds (we call this risk). But like the gambler who hits an inside straight when they’re all-in, every once in a while, you can win when the cards are stacked against you. Sometimes. Data mining through conversation identifies risk too, but it also assesses social determinants of health, gives insight into ancillary indications, and can illuminate potential contributing factors.
Behavior informs health. But external forces, like those found within the umbrella of social determinants of health, often drive behaviors, both good and bad. And the answer to, “Do you have a healthy friend group that helps you relieve stress” will never show up in results from a swab.
Genetic testing is a one-way equation. Data in, results out. But precision medicine only starts with data gathering. It also requires translating that data into actionable insights. Then, it requires data delivery in the form of conversation.
As 2020 brings more and more data into the healthcare fold, it becomes more and more important to know how to gather and process that data into action. That’s why our platform has been so successful, because it connects parts of the care continuum that typically haven’t exchanged data or messaging effectively. Now they can. And patients benefit.
This is our second post on 2020 trends. The other talks about how personalization is the new bedside manner. You can read it here. Or, if you’d like to find out how our platform drives affordability and increases adherence, schedule a demo today.